Pharmaceutical Industry Articles & Reports - Page 5

Analyze the 2026 biotech capital outlook, detailing Blackstone's record $6.3B Life Sciences Fund VI, VC funding trends, biopharma M&A, and market recovery.

Review the 2026 pharma AI vendor landscape. This analysis details 150+ companies using machine learning for drug discovery, clinical trials, and manufacturing.

Analyze the BeOne-Huahui licensing agreement for the HH160 PD-1/CTLA-4/VEGF trispecific antibody. Review recent China biotech cross-border licensing trends.

Examine the FDA approval of Otarmeni, the first gene therapy for OTOF-related congenital hearing loss, and its expedited National Priority Voucher review.

Analyze AcuityMD's $80M Series C funding and the role of AcuityAI. Learn how agentic AI optimizes MedTech commercial operations, sales, and market access.

Analyze how AI clinical trial recruitment addresses enrollment bottlenecks. This report examines Iterative Health's $77M expansion into cardiology and obesity.

Examine the $2.25B Eli Lilly-Profluent deal. Learn how generative AI and protein design are creating novel recombinases for kilobase-scale genome editing.

A 2026 comparison guide of open-source LIMS platforms for life science labs. Learn about system architectures, customizability, and compliance trade-offs.

Examine the 2026 FDA real-time clinical trial pilot. This report analyzes how AI and cloud platforms enable continuous oncology data monitoring for new drugs.

Understand why large language models (LLMs) improve performance when given high-stakes or emotional prompts, and explore research on the EmotionPrompt effect.

Analyze LLM position bias, including primacy and recency effects in transformer models. Learn how prompt structure impacts attention and generation accuracy.

Examine the FDA's first warning letter for AI misuse in cGMP manufacturing. This review details compliance lessons and human oversight requirements for QA.

Examine the impact of Novartis CEO Vas Narasimhan joining Anthropic's board. This report analyzes pharma AI governance, healthcare regulations, and drug R&D.

Review this 2026 vendor comparison of clinical trial payment software. Analyze automated site payment and participant stipend management system capabilities.

Analyze Q1 2026 biopharma M&A trends, including 19 billion-dollar deals. Learn how patent cliffs and AI valuation drivers impact pharmaceutical acquisitions.

Analyze the role of multi-agent AI and co-scientist architectures, including withZeta.ai, in accelerating rare cancer drug discovery and modern oncology R&D.

Review AI molecule prioritization methods and computational triage tools used in drug discovery pipelines to filter generative AI candidates via ADMET and QSAR.

Read a comprehensive analysis of Veeva's Ostro acquisition. Learn how conversational AI integrates with Vault CRM for MLR-compliant HCP and patient engagement.

Review essential features of Anatomic Pathology LIMS, including digital pathology integration, compliance, and workflows for histopathology and cytology.

Examine how Isomorphic Labs uses AlphaFold AI to advance its first computationally designed oncology and immunology therapeutics into clinical trials.

Explore the updated EU GMP Annex 1 guidelines for sterile manufacturing. Learn how to implement a risk-based Contamination Control Strategy (CCS) for compliance

Understand how AI automates regulatory medical writing for CTD Module 2 summaries in IND and NDA submissions, including efficiency gains and compliance risks.

Analyze the AI-enabled precision proteomics market through the Alamar Biosciences $191M IPO, NULISA technology, and the future of protein biomarker detection.

Learn about CDISC SEND datasets for FDA nonclinical submissions. This guide explains SDTM framework alignment, SENDIG rules, and regulatory compliance timelines